Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...
A novel intranasal drug delivery system for brain tumors is advancing clinical trials in India, offering a non-invasive, ...
The HIV cases were identified during routine screenings conducted by the Kerala AIDS Control Society as part of the state’s ...
In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that help the blood clot was ...
Merck’s pembrolizumab with berahyaluronidase alfa demonstrates noninferior PK compared to IV Keytruda in pivotal 3475A-D77 trial: Rahway, New Jersey Saturday, March 29, 2025, 10 ...
The committee based its decision on data showing the subcutaneous formulation of Opdivo was not inferior to the intravenous formulation.
Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...
WESTLAKE VILLAGE, Calif., March 28, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, reported fourth quarter and full year 2024 financial ...